Full-Time

Senior Director Medical Affairs

Rare Disease

Updated on 5/17/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology

Senior

San Diego, CA, USA

Required Skills
Communications
Requirements
  • MD, Ph.D., PharmD, or equivalent degree
  • 10 years of experience in pharmaceutical or biotech industry
  • Rare disease experience
  • Strong strategic and execution skills
  • Ability to work closely with HCPs in rare disease space
  • Excellent written and oral communication skills
  • Strong interpersonal skills
  • Knowledge of scientific methods and medical practices
  • Ability to travel
Responsibilities
  • Lead the development and execution of medical strategy for Rett Syndrome
  • Provide scientific and medical leadership
  • Establish strategic partnerships with centers of excellence and advocacy groups
  • Lead design and execution of medical plan and tactics
  • Lead phase IV studies and oversee CROs
  • Provide medical expertise in data dissemination
  • Engage with Key Opinion Leaders and scientific leaders
  • Assist in publication activities
  • Contribute to Development plans
  • Other duties as assigned

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals Inc. stands out as a leader in the niche field of neurological and mental health therapy development, particularly focusing on conditions like schizophrenia, Parkinson's disease psychosis, and Rett syndrome. This specialization not only brings significant advancement in targeted therapies but also enhances the quality of life for individuals enduring these challenging conditions. Working at this company offers the chance to be part of a dedicated team that positively impacts patient lives through groundbreaking work in a highly specialized area of medicine.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

San Diego, California

Founded

1993

Growth & Insights
Headcount

6 month growth

8%

1 year growth

14%

2 year growth

20%